glp 1 is not working The science of GLP1 medicine for some people ☝️ Why GLP-1 Isn't Working: Causes

Ma H, Huang W, Wang X et al (2020) Structural insights into the activation of GLP-1R by a small molecule agonist

The tirzepatide drugs, such as Mounjaro and Zepbound, target the GLP-1 pathway along with a second one, the GIP pathway

Because of the overlapping mechanisms of dipeptidyl peptidase 4 (DPP-4) inhibitors with GLP-1 RA it may be reasonable to use as a temporary replacement

With GLP-1/GIP/GCGR triagonists and next-generation combination drugs like CagriSema , these therapies could soon become the gold standard for treating metabolic disorders

This drastically reduces sublingual absorption and forces most of the medication through the GI tract, where bioavailability plummets